livehealth.store

Tivicay recalls

Tivicay products have been recalled 3 times, most recently on 12 Jun 2024. The recalling company is usually GlaxoSmithKline.

Total recalls3since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 12 Jun 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 3 100%

Why tivicay is recalled

Other Reasons3100%

Companies

GlaxoSmithKline267%
Viiv Healthcare133%

By year

2024133%
2022133%
2014133%

All tivicay recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
12 Jun 2024Drug	CLASS III	Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension recalledTivicay	GlaxoSmithKline	Other	Nationwide
1 Jun 2022Drug	CLASS III	Tivicay (dolutegravir) Tablets 50 mg recalled by GlaxoSmithKlineTivicay	GlaxoSmithKline	Other	Nationwide
9 Apr 2014Drug	CLASS III	Tivicay (dolutegravir) Tablets 50 mg recalled by Viiv HealthcareTivicay	Viiv Healthcare	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.